A Critical Look at the Impact of Joanna Moncrieff’s “Chemical Imbalance” Umbrella Review
Who read the article in Molecular Psychiatry? Who disseminated it? Who threatens and bullies critics of Moncrieff’s article?
The publicity campaign that relies on Moncrieff’s Molecular Psychiatry article to discourage the use of antidepressants is not a move in a controversy within academic medicine.
It is a well-orchestrated attack on academic psychiatry from a few psychiatrists who won’t even identify the specific colleagues they are targeting or document that these colleagues even say the things that Moncreiff attributes to them. The success of the campaign depends on persons brought in from outside academia, some of whom reject basic academic values and rely on hateful intimidation and threats to careers and reputations to quell opposition to the antipsychiatry messages of Moncrieff’s campaign.
This article is the follow-up Part 2 to Is Moncrieff’s Chemical Imbalance Paper a Decent Systematic Umbrella Review? Part 1.
My earlier Substack article pointed to a growing consensus among experts about how to plan, execute, and report a systematic umbrella review if the goal were to …